Biofrontera Inc. (BFRI) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Biofrontera Inc.
Address
120 Presidential Way
Woburn, MA 01801
United States of America (the)
Phone
781 245 1325
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
92
First IPO Date
October 29, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Hermann Luebbert | Chief Executive Officer, President & Chairman | 687,482 | 1956 |
| George Jones | Chief Commercial Officer | 275,184 | 1973 |
| Eugene Frederick Leffler | Chief Financial Officer | 461,333 | 1985 |
| Daniel Hakansson | Senior Corporate Counsel | 0 | N/A |
| Jon Lyons | Vice President of Scientific & Medical Affairs | 0 | N/A |
| Erica F. Gates | VP of Finance & Principal Accounting Officer | 0 | N/A |
| Samantha Widdicombe | Senior Vice President of Sales & Strategic Accounts | 0 | N/A |
Description
Biofrontera Inc. is a biopharmaceutical enterprise dedicated to the marketing and distribution of pharmaceutical products within the United States, specifically targeting various dermatological conditions. The company's portfolio includes Ameluz, a prescribed medication designed for photodynamic therapy. This treatment, utilized in conjunction with its licensor's RhodoLED lamp series, addresses mild-to-moderate actinic keratosis on the face and scalp through both localized (lesion-directed) and broader area (field-directed) applications. Furthermore, Biofrontera offers Xepi, a prescription cream indicated for the treatment of impetigo. The firm was founded in 2015 and operates from its headquarters located in Woburn, Massachusetts.
